Clinical Trial Update: Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating montelukast for sickle cell anemia has completed; results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0) | Phase 2 | Status: COMPLETED | Results posted: 2019-03-26